13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Broadly Neutralizing Antibody Epitopes on HIV-1 Particles are exposed after Virus Interaction with Host Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          HIV-1 envelope glycoproteins (Env) are critical for infection and are key targets for vaccine development. Env proteins displayed on virions are conformationally diverse, comprising both functional and non-functional forms. These heterogeneous Env populations have important implications for neutralizing and non-neutralizing antibody elicitation and functions. This study aimed to interrogate the antigenic composition of Env on virions. Using a flow cytometry-based assay we show that only some epitopes including V2i, gp120-g41 interface, and gp41-MPER are accessible on HIV-1 particles, while V3, V2q, and select CD4bs epitopes are obscured for monoclonal antibody (mAb) binding. To investigate the mechanisms contributing to the masking of these epitopes we first asked whether time-dependent dynamics of Env can affect their exposure. Extending the time of virus-mAb interaction increased the binding of mAbs, epitopes of which were already accessible on virions but not those that are occluded. However, the occluded epitopes became accessible after conformational unmasking was induced by pre-binding of select mAbs, prompting us to test if similar conformational changes are required for these mAbs to exhibit their neutralization capability. We tested HIV-1 neutralization where virus-mAb mix was incubated or not incubated for one-hour prior to adding the target cells. Similar levels of neutralization were observed under both assay conditions, suggesting that interaction between virus and cells sensitizes the virions for neutralization via broadly-neutralizing antibodies (bNAbs). These findings provide insight into how bNAbs may gain access to these occluded epitopes to exert their neutralization effects. Further studies with larger virus and mAb panels are warranted.

          Related collections

          Most cited references129

          • Record: found
          • Abstract: found
          • Article: not found

          Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

          Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spike, the main target of neutralizing antibodies. To understand the impact of these variants, we evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2. Five of the 10 pseudoviruses, harboring receptor-binding domain mutations, including K417N/T, E484K, and N501Y, were highly resistant to neutralization. Cross-neutralization of B.1.351 variants was comparable to SARS-CoV and bat-derived WIV1-CoV, suggesting that a relatively small number of mutations can mediate potent escape from vaccine responses. While the clinical impact of neutralization resistance remains uncertain, these results highlight the potential for variants to escape from neutralizing humoral immunity and emphasize the need to develop broadly protective interventions against the evolving pandemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mechanisms of viral membrane fusion and its inhibition.

            Viral envelope glycoproteins promote viral infection by mediating the fusion of the viral membrane with the host-cell membrane. Structural and biochemical studies of two viral glycoproteins, influenza hemagglutinin and HIV-1 envelope protein, have led to a common model for viral entry. The fusion mechanism involves a transient conformational species that can be targeted by therapeutic strategies. This mechanism of infectivity is likely utilized by a wide variety of enveloped viruses for which similar therapeutic interventions should be possible.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

              The human immunodeficiency virus-type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1 envelope glycoproteins and, ultimately, aid in HIV-1 vaccine development.
                Bookmark

                Author and article information

                Journal
                bioRxiv
                BIORXIV
                bioRxiv
                Cold Spring Harbor Laboratory
                21 January 2023
                : 2023.01.20.524996
                Affiliations
                [a ]Division of Infectious Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
                Author notes
                [* ] Address correspondence to chitra.upadhyay@ 123456mssm.edu
                Article
                10.1101/2023.01.20.524996
                9882293
                36711466
                f843448e-bcb1-4968-8849-5daba5cf80cc

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

                History
                Categories
                Article

                human immunodeficiency virus,neutralization,antibodies,broadly neutralizing antibodies (bnabs),non-neutralizing antibodies (nnabs),envelope conformations

                Comments

                Comment on this article